Posts

October 24, 2014

+
11:56 AM | Coming ever closer – first PARP inhibitor on track to be licensed in Europe
Olaparib is the first PARP inhibitor to move closer to licensing in Europe. What is it, how does it work, and when will it be available in the UK?

October 22, 2014

+
5:00 PM | Science Snaps: peering inside an expanding lymph node
Our scientists have shown for the first time how lymph nodes swell during infection, producing some striking images along the way.

October 21, 2014

+
9:29 AM | Biotherapeutics – a new funding scheme for research
Our latest funding scheme focuses on the emerging field of biotherapeutics – smarter cancer treatments based on cells and biological molecules.

October 14, 2014

+
6:00 PM | A chemical ‘breadcrumb trail’ helps melanoma spread
Our scientists have found that melanoma cells follow the ‘trail’ of a naturally-occurring molecule in the body, encouraging them to spread.

October 09, 2014

+
6:00 PM | Lung cancer evolution – a journey through space and time
Two new studies reveal the processes in our cells that cause lung cancers develop - a process that can take more than twenty years.

October 06, 2014

+
9:45 AM | Understanding how cells divide – the story of a Nobel prize
In 2001, our researchers Tim Hunt and Paul Nurse won a share of the Nobel prize for physiology or medicine. We look back at their achievements.

October 03, 2014

+
3:48 PM | Citizen Science: “you don’t need to be qualified to do this”
To mark the launch of our latest Citizen Science game, Reverse The Odds, we caught up with one the researchers that you'll be helping by playing the game.

September 26, 2014

+
12:26 PM | Classifying leukaemia: one size doesn’t fit all
A landmark research paper in 1977 changed the way children with acute leukaemia are diagnosed and treated. We look at the story of a research milestone.
1
8 Results